PsyRX CNS Bio-Tech Ltd (TLV:PSRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 76.40
+0.10 (0.13%)
At close: Sep 1, 2026
PsyRX CNS Bio-Tech Market Cap
PsyRX CNS Bio-Tech has a market cap or net worth of 7.81 million as of September 2, 2026. Its market cap has increased by 101.23% in one year.
Market Cap
7.81M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
76.40
ChartMarket Cap Chart
Since July 25, 2021, PsyRX CNS Bio-Tech's market cap has decreased from 329.34M to 7.81M, a decrease of -97.63%. That is a compound annual growth rate of -51.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 7.81M | -20.17% |
| Dec 31, 2025 | 9.79M | 100.78% |
| Dec 31, 2024 | 4.87M | -44.97% |
| Dec 31, 2023 | 8.86M | -64.09% |
| Dec 29, 2022 | 24.66M | -59.42% |
| Dec 30, 2021 | 60.77M | -81.55% |
| Jul 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 125.84B |
| Danel (Adir Yeoshua) | 2.58B |
| Amal Holdings A.D. | 2.25B |
| BrainsWay | 1.73B |
| Purple Biotech | 18.65M |
| Erika Carmel-Tech | 18.37M |
| Nextage Therapeutics | 12.06M |
| Bio-View | 10.73M |